Special Issue "Recent Developments in HTLV Research"

Quicklinks

A special issue of Viruses (ISSN 1999-4915). This special issue belongs to the section "Animal Viruses".

Deadline for manuscript submissions: closed (31 March 2011)

Special Issue Editor

Guest Editor
Prof. Dr. Susan Marriott
Department of Molecular Virology and Microbiology Director, Graduate Program in Cell and Molecular Biology, Baylor College of Medicine, MS-385 One Baylor Plaza Houston, TX 77030, USA
Website: http://www.bcm.edu/cmb/index.cfm?pmid=2354
E-Mail: susanm@bcm.edu
Phone: +1 713 798 4440
Fax: +1 713 798 4435

Special Issue Information

Human T-lymphotropic retrovirus types 1 and 2 (HTLV-1 and HTLV-2) were discovered in the early 1980’s.  These viruses are now estimated to infect up to 14 million (HTLV-1) and several million (HTLV-2) people worldwide.  HTLV-1 causes a T-lymphocytic malignancy known as adult T-cell leukemia/lymphoma (ATLL) in about 2 percent of those infected, and a neurologic disorder called HTLV-associated myelopathy (HAM) in another 2 to 3 percent.  HTLV-2 does not cause ATLL, but does cause HAM in 1 to 2 percent of infected individuals.  These viruses serve as excellent models for the epidemiology and pathogenesis of viral-associated cancers, other human retroviral infections, and autoimmune conditions such as multiple sclerosis.  The recent discovery of two new members of the HTLV family, HTLV-3 and HTLV-4 in Central African bushmeat hunters emphasizes the need for continued surveillance for new human retroviruses and analysis of these new viruses for disease-causing potential.  HTLV-1 encodes a viral oncoprotein, Tax-1, which is necessary and sufficient for viral transformation while the HTLV-2 Tax-2 protein does not cause tumors in animal models.  Other regulatory proteins encoded by HTLVs include the HTLV-1 basic leucine zipper factor (HBZ), which is encoded on an anti-sense viral transcript and inhibits Tax mediated viral gene expression.  The HTLV-1 p30II protein is also an agonist for Tax-mediated transcription and is a multifunctional repressor of cellular gene expression.
HTLV-1 mediated leukemogenesis is a topic of intense investigation.  Current research efforts are focused on the effects of Tax on cellular transcription and consequent perturbations of genome stability and cell cycle control, role of regulatory proteins
such as HBZ and p30II in HTLV pathogenesis, mechanisms of viral entry, and development of therapeutic approaches.  Research into the pathogenesis of HAM will provide important insights into this disease as well as a model for other neuroimmunologic diseases. Although the basic epidemiology of HTLV-1 and -2 has been reasonably well defined, important public health issues remain to be addressed, including patterns of emergence into new host populations, prevention of transmission, improved confirmatory tests for blood donor screening, and the potential for HTLV-3 and HTLV-4 to be transmitted from person-to-person and to cause human disease.  Ongoing clinical research is needed to develop potential HTLV-I and –II vaccines, and treatments for ATL and HAM.  This special issue will contain reviews and updates on recent advances in research focused on each of these areas.

Keywords

  • human T cell leukemia virus
  • adult T cell leukemia
  • HTLV-associated myelopathy
  • HBZ/APH
  • tax
  • accessory proteins p30, p12, p13
  • new HTLV viruses
  • transcription control
  • cell cycle/senescence
  • genome instability
  • clinical trials
  • animal models
  • viral entry
  • epidemiology
  • pathogenesis

Published Papers (23 papers)

Viruses 2011, 3(11), 2146-2159; doi:10.3390/v3112146
Received: 20 September 2011; Accepted: 22 October 2011 / Published: 2 November 2011
Show/Hide Abstract | Download PDF Full-text (1149 KB)

Viruses 2011, 3(10), 1815-1835; doi:10.3390/v3101815
Received: 13 September 2011; Accepted: 26 September 2011 / Published: 10 October 2011
Show/Hide Abstract | Download PDF Full-text (1431 KB)

Viruses 2011, 3(9), 1532-1548; doi:10.3390/v3091532
Received: 2 June 2011; in revised form: 13 August 2011 / Accepted: 16 August 2011 / Published: 25 August 2011
Show/Hide Abstract | Download PDF Full-text (1676 KB)

Viruses 2011, 3(8), 1485-1500; doi:10.3390/v3081485
Received: 4 August 2011; Accepted: 10 August 2011 / Published: 18 August 2011
Show/Hide Abstract | Download PDF Full-text (437 KB)

Viruses 2011, 3(8), 1439-1459; doi:10.3390/v3081439
Received: 7 July 2011; in revised form: 25 July 2011 / Accepted: 8 August 2011 / Published: 16 August 2011
Show/Hide Abstract | Download PDF Full-text (484 KB)

Viruses 2011, 3(8), 1395-1414; doi:10.3390/v3081395
Received: 5 July 2011; in revised form: 28 July 2011 / Accepted: 28 July 2011 / Published: 11 August 2011
Show/Hide Abstract | Download PDF Full-text (314 KB)

Viruses 2011, 3(8), 1374-1394; doi:10.3390/v3081374
Received: 23 June 2011; in revised form: 20 July 2011 / Accepted: 1 August 2011 / Published: 8 August 2011
Show/Hide Abstract | Download PDF Full-text (749 KB)

Viruses 2011, 3(8), 1320-1331; doi:10.3390/v3081320
Received: 13 June 2011; in revised form: 22 July 2011 / Accepted: 23 July 2011 / Published: 2 August 2011
Show/Hide Abstract | Download PDF Full-text (343 KB)

Viruses 2011, 3(7), 1210-1248; doi:10.3390/v3071210
Received: 21 May 2011; in revised form: 28 June 2011 / Accepted: 29 June 2011 / Published: 19 July 2011
Show/Hide Abstract | Download PDF Full-text (306 KB)

Viruses 2011, 3(7), 1131-1165; doi:10.3390/v3071131
Received: 9 May 2011; in revised form: 1 July 2011 / Accepted: 2 July 2011 / Published: 12 July 2011
Show/Hide Abstract | Download PDF Full-text (471 KB)

Viruses 2011, 3(7), 1074-1090; doi:10.3390/v3071074
Received: 11 May 2011; in revised form: 21 June 2011 / Accepted: 6 July 2011 / Published: 8 July 2011
Show/Hide Abstract | Download PDF Full-text (395 KB)

Viruses 2011, 3(7), 1041-1058; doi:10.3390/v3071041
Received: 17 May 2011; in revised form: 17 June 2011 / Accepted: 17 June 2011 / Published: 5 July 2011
Show/Hide Abstract | Download PDF Full-text (762 KB)
abstract graphic

Viruses 2011, 3(7), 1001-1014; doi:10.3390/v3071001
Received: 9 May 2011; in revised form: 9 June 2011 / Accepted: 11 June 2011 / Published: 27 June 2011
Show/Hide Abstract | Download PDF Full-text (207 KB)

Viruses 2011, 3(6), 886-900; doi:10.3390/v3060886
Received: 27 April 2011; in revised form: 7 June 2011 / Accepted: 9 June 2011 / Published: 21 June 2011
Show/Hide Abstract | Download PDF Full-text (743 KB)

Viruses 2011, 3(6), 861-885; doi:10.3390/v3060861
Received: 13 April 2011; in revised form: 25 May 2011 / Accepted: 26 May 2011 / Published: 17 June 2011
Show/Hide Abstract | Download PDF Full-text (499 KB)

Viruses 2011, 3(6), 829-857; doi:10.3390/v3060829
Received: 14 May 2011; in revised form: 31 May 2011 / Accepted: 1 June 2011 / Published: 15 June 2011
Show/Hide Abstract | Download PDF Full-text (1194 KB)

Viruses 2011, 3(6), 794-810; doi:10.3390/v3060794
Received: 20 April 2011; in revised form: 20 May 2011 / Accepted: 23 May 2011 / Published: 15 June 2011
Show/Hide Abstract | Download PDF Full-text (536 KB)
abstract graphic

Viruses 2011, 3(6), 770-793; doi:10.3390/v3060770
Received: 15 April 2011; in revised form: 20 May 2011 / Accepted: 20 May 2011 / Published: 14 June 2011
Show/Hide Abstract | Download PDF Full-text (578 KB)

Viruses 2011, 3(6), 750-769; doi:10.3390/v3060750
Received: 8 April 2011; in revised form: 16 May 2011 / Accepted: 17 May 2011 / Published: 14 June 2011
Show/Hide Abstract | Download PDF Full-text (195 KB)

Viruses 2011, 3(6), 714-749; doi:10.3390/v3060714
Received: 2 April 2011; in revised form: 13 May 2011 / Accepted: 1 June 2011 / Published: 10 June 2011
Show/Hide Abstract | Download PDF Full-text (559 KB)

Viruses 2011, 3(5), 541-560; doi:10.3390/v3050541
Received: 26 March 2011; Accepted: 26 April 2011 / Published: 9 May 2011
Show/Hide Abstract | Download PDF Full-text (586 KB)

Viruses 2011, 3(5), 469-483; doi:10.3390/v3050469
Received: 25 February 2011; in revised form: 6 April 2011 / Accepted: 21 April 2011 / Published: 5 May 2011
Show/Hide Abstract | Download PDF Full-text (308 KB)

Viruses 2011, 3(5), 456-468; doi:10.3390/v3050456
Received: 9 March 2011; in revised form: 14 April 2011 / Accepted: 15 April 2011 / Published: 5 May 2011
Show/Hide Abstract | Download PDF Full-text (229 KB)
abstract graphic

Last update: 5 March 2014

Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert